A Polysomnographic Study Of Single-Dose Gabapentin In Transient Insomnia
Status:
Completed
Trial end date:
2006-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the effect of gabapentin on polysomnographic
assessments in transient insomnia induced by a sleep phase advance.
Phase:
Phase 3
Details
Lead Sponsor:
Pfizer Pfizer's Upjohn has merged with Mylan to form Viatris Inc.